UC San Diego Health, the region’s only academic medical center, delivers world-class care and translates groundbreaking research into promising new treatments for patients.
Researchers at UC San Diego Health have joined a national research study called Hyperbaric Oxygen Brain Injury Treatment (HOBIT) to assess whether therapy involving 100 percent oxygen under pressure might also benefit patients with severe brain injuries.
UC San Diego clinical trial suggests ivabradine may be effective in treating postural orthostatic tachycardia syndrome, a potential COVID-19 long-hauler symptom.
A team of American and Canadian researchers report that while they may feel uncomfortable, there is little empirical evidence that wearing a face mask significantly diminishes lung function, even when worn during heavy exercise.
Researchers at University of California San Diego School of Medicine report that fructose only adversely affects the liver after it reaches the intestines, where the sugar disrupts the epithelial barrier protecting internal organs from bacterial toxins in the gut.
University of California San Diego School of Medicine scientists say the loss of a single gene two to three million years ago in our ancestors may have resulted in a heightened risk of cardiovascular disease in all humans as a species, while also setting up a further risk for red meat-eating humans.
Researchers confirm effectiveness of early screening tool to identify infants with autism, prompting earlier treatment, but key is parental involvement.
Men's Health, August 10
Becker's Hospital Review, August 12
Nature, August 13
Fierce Healthcare, August 12
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
